Burton W N, Connerty C M, Schultz A B, Chen C Y, Edington D W
Bank One, 1 Bank One Plaza, Mail Code: IL1-0006, Chicago, IL 60670-0006, USA.
J Occup Environ Med. 2001 Feb;43(2):75-82. doi: 10.1097/00043764-200102000-00001.
Non-occupational asthma is a common disease affecting approximately 6% of the US population. Asthma accounts for an estimated 3 million workdays lost each year in the United States and for reduced employee job productivity. Although asthma disease management programs are relatively common in managed care organizations, they generally have not been offered at the workplace. A total of 168 employees with asthma were identified, and 76 participated in a worksite asthma disease management program. Of them, 41 (53.9%) completed an Asthma Therapy Assessment Questionnaire (ATAQ) at baseline, post-program (2 months), 4 months, and 12 months. The total ATAQ Index declined from 3.59 at baseline to 2.76 at 12 months (p < 0.01). After the program, significantly more employees reported using controller medications (the desired behavior) rather than reliever medications. A worksite-based disease management program for asthma should reduce medical care costs and absenteeism and improve worker productivity.
非职业性哮喘是一种常见疾病，影响着约6%的美国人口。在美国，哮喘估计每年导致300万个工作日的损失以及员工工作效率的降低。尽管哮喘疾病管理项目在管理式医疗组织中相对常见，但它们通常未在工作场所提供。总共识别出168名患有哮喘的员工，其中76人参加了工作场所哮喘疾病管理项目。在这些人中，41人（53.9%）在基线、项目结束后（2个月）、4个月和12个月时完成了哮喘治疗评估问卷（ATAQ）。ATAQ总指数从基线时的3.59降至12个月时的2.76（p < 0.01）。项目结束后，报告使用控制药物（期望行为）而非缓解药物的员工显著增多。基于工作场所的哮喘疾病管理项目应能降低医疗成本和缺勤率，并提高员工生产力。
